Relmada Therapeutics Inc
(STU:4E2)
€
5.65
(0%)
Market Cap: 590.95 Mil
Enterprise Value: 385.50 Mil
PE Ratio: 0
PB Ratio: 3.12
GF Score: 22/100 Relmada Therapeutics Inc (STU:4E2) Transcripts
- 1